ArticleFrontiers in immunology2022

Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants.

Qi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.